Clinical Trial

Intervention With General Practitioners to Improve Women's Participation in Cervical Cancer Screening

Study acronym: INDIGO
Recruiting
View on ClinicalTrials.gov →
Summary
In France, cervical cancer is the 12th most common female cancer with nearly 3,000 new cases per year. Since 2018, a national Organized Cervical Cancer Screening program (DOCCU) has been set up and concerns all asymptomatic women aged 25 to 65. This program, managed by the Regional Cancer Screening Coordination Centers (CRCDC), invites women who have not taken a sample within the recommended time frame to consult for screening. However, only 59% of patients participated. The intervention of the general practitioner, an essential player in prevention, could allow for better awareness. The objective of the INDIGO study is to evaluate the effectiveness of the intervention of a general practitioner on the participation rate in the DOCCU of patients who are not up to date with their screening.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-07-25; most recent amendment 2026-04-09.
Status change: Not Yet Recruiting → Recruiting 2026-04-09
Trial Details
NCT Number NCT06527456
Lead Sponsor Centre Hospitalier Intercommunal Creteil
Conditions Cervical Cancer
Enrollment 11,200 participants
Start Date 2026-01-21
Primary Completion 2027-08 (estimated)
Study Completion 2027-08 (estimated)
Updated on ClinicalTrials.gov 2026-04-14